Patients younger than 40 experience higher rates of CINV and more commonly use marijuana, diet changes, and other methods to manage symptoms. Data presented at the 23rd Annual American Psychosocial ...
Data presented at the APOS Annual Conference showed sexual function issues and a web-based intervention for AYA cancer survivors. Adolescence and young adulthood (AYA) represent a critical ...
Jamie S. Myers, PhD, RN, AOCNS, FAAN, shares insights from a career of oncology nursing research, including advice for those new to the field. Welcome to Onc Nurse On Call, the new podcast ...
A study that evaluated over 4000 patients with breast cancer found that, with a median follow-up of 18 years, history of ...
Mastectomy can have major impacts on the life of a person with breast cancer, from body image issues to sexual and ...
What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...
C, MPH, stressed that nurses can take advantage of accessible and local integrative medicine resources to treat patients with cancer. Nurses are poised to offer a glimpse into integrative medicine ...
A real-world study found rates of toxicity-related T-DXd discontinuation in HER2-low metastatic breast cancer similar to those observed in DESTINY-Breast04. A real-world cohort of patients with ...
Dizon, MD, FACP, FASCO, shared insights on what pregnancy looks like with a breast cancer diagnosis and what those considering pregnancy should know. For young patients with breast cancer, pregnancy ...
Having dealt with difficult-to-diagnose breast cancer herself, Patricia Jakel, MN, RN, AOCN, is all too familiar with the need for vigilant monitoring, even when that goes beyond what is recommended.
A significant portion of patients with locally advanced breast cancer receiving ultra-hypofractionation radiotherapy responded to treatment. Ultra-hypofractionated radiotherapy showed signs of ...
Data show that sentinel lymph node biopsy is becoming less routine for older women with breast early stage HR-positive, HER2-negative breast cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results